Lorenza Sisinni
Potenza, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 26 publications
Biological evaluation of [4-(4-aminophenyl)-1-(4-fluorophenyl)-1H-pyrrol-3-yl](3,4,5-trimethoxyphenyl)methanone as potential antineoplastic agent in 2D and 3D breast cancer models.
Journal: Archiv der Pharmazie
Published: July 01, 2023
Heat shock proteins in cancer stem cell maintenance: A potential therapeutic target?
Journal: Histology and histopathology
Published: July 20, 2019
Comparative Gene Expression Profiling of Tobacco-Associated HPV-Positive versus Negative Oral Squamous Carcinoma Cell Lines.
Journal: International journal of medical sciences
Published: March 22, 2019
Endoplasmic Reticulum Stress and Unfolded Protein Response in Breast Cancer: The Balance between Apoptosis and Autophagy and Its Role in Drug Resistance.
Journal: International journal of molecular sciences
Published: January 14, 2019
IL6/STAT3 axis mediates resistance to BRAF inhibitors in thyroid carcinoma cells.
Journal: Cancer letters
Published: May 23, 2018
Cyclin-dependent kinase 1 targeting improves sensitivity to radiation in BRAF V600E colorectal carcinoma cells.
Journal: Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine
Published: April 18, 2018
New TRAP1 and Hsp90 chaperone inhibitors with cationic components: Preliminary studies on mitochondrial targeting.
Journal: Bioorganic & medicinal chemistry letters
Published: January 23, 2018
Uncommon frame-shift exon 19 EGFR mutations are sensitive to EGFR tyrosine kinase inhibitors in non-small cell lung carcinoma.
Journal: Medical oncology (Northwood, London, England)
Published: November 22, 2017
Dual EGFR and BRAF blockade overcomes resistance to vemurafenib in BRAF mutated thyroid carcinoma cells.
Journal: Cancer cell international
Published: July 03, 2017
TRAP1: a viable therapeutic target for future cancer treatments?
Journal: Expert opinion on therapeutic targets
Published: July 01, 2017
TRAP1 controls cell cycle G2-M transition through the regulation of CDK1 and MAD2 expression/ubiquitination.
Journal: The Journal of pathology
Published: December 22, 2016
TRAP1 protein signature predicts outcome in human metastatic colorectal carcinoma.
Journal: Oncotarget
Published: November 02, 2016
Last Updated: 09/26/2026